Advertisement

Ads Placeholder
Loading...

Genscript Biotech Corporation

GNNSF•PNK
Healthcare
Biotechnology
$1.42
$0.00(0.00%)
U.S. Market opens in 3h 36m

Genscript Biotech Corporation (GNNSF) Stock Overview

Explore Genscript Biotech Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.1B
P/E Ratio-5.84
EPS (TTM)$-0.25
ROE-0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$1.19
3 Months$2.43
1 Year Target$1.97

GNNSF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Genscript Biotech Corporation (GNNSF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.12, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.97.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.84 and a market capitalization of 3.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
8.40%
3-Month Change
-22.83%
6-Month Change
-35.45%
Year-to-Date (YTD) Change
-22.83%
1-Year Change
10.94%
3-Year Change
-32.89%
5-Year Change
-29.35%
All-Time (Max) Change
59.55%

Contact Information

https://www.genscript.com
86 25 5889 7288
Jiangning Science Park, Nanjing, NaN, 211100

Company Facts

55,680 Employees
IPO DateSep 28, 2017
CountryCN
Actively Trading

Frequently Asked Questions